We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Mitek Systems
MITK
$756M
| $1.17M | 0.01% |
92,039
-1,490
| -2% | -$16.8K |
|
|
KBAL
627
DELISTED
Kimball International
KBAL
| $1.17M | 0.01% |
+110,626
| New | +$1.23M |
|
628
Amneal Pharmaceuticals
AMRX
$6.1B
| $1.17M | 0.01% |
300,273
+230,224
| +329% | +$985K |
|
629
ON Semiconductor
ON
$30.7B
| $1.16M | 0.01% |
53,625
-62,339
| -54% | -$1.32M |
|
|
CHMA
630
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $1.16M | 0.01% |
269,987
+138,864
| +106% | +$665K |
|
|
HARP
631
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $1.16M | 0.01% |
6,823
+1,186
| +21% | +$171K |
|
|
ZAGG
632
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $1.15M | 0.01% |
412,080
+21,787
| +6% | +$68.3K |
|
633
Pixelworks
PXLW
$37.2M
| $1.15M | 0.01% |
46,547
+17,973
| +63% | +$581K |
|
|
ZGNX
634
DELISTED
Zogenix, Inc.
ZGNX
| $1.15M | 0.01% |
63,840
+188
| +0.3% | +$4.61K |
|
635
United Fire Group
UFCS
$1.35B
| $1.14M | 0.01% |
56,304
+39,816
| +241% | +$996K |
|
|
IMGN
636
DELISTED
Immunogen Inc
IMGN
| $1.14M | 0.01% |
316,101
-208,336
| -40% | -$841K |
|
|
DOC
637
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $1.13M | 0.01% |
63,200
-25,417
| -29% | -$453K |
|
638
Merchants Bancorp
MBIN
$2.49B
| $1.13M | 0.01% |
85,808
-9,315
| -10% | -$118K |
|
|
DRNA
639
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.13M | 0.01% |
62,645
-10,927
| -15% | -$226K |
|
|
SUM
640
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $1.11M | 0.01% |
+68,391
| New | +$1.09M |
|
|
PRSP
641
DELISTED
Perspecta Inc. Common Stock
PRSP
| $1.11M | 0.01% |
57,187
-146,716
| -72% | -$3.1M |
|
642
NorthWestern Energy
NWE
$4.34B
| $1.11M | 0.01% |
22,731
-307
| -1% | -$16.3K |
|
643
Tenet Healthcare
THC
$22.2B
| $1.1M | 0.01% |
44,810
-1,954
| -4% | -$49.9K |
|
644
Scholar Rock
SRRK
$5.88B
| $1.09M | 0.01% |
61,846
+31,606
| +105% | +$470K |
|
|
LBAI
645
DELISTED
Lakeland Bancorp Inc
LBAI
| $1.09M | 0.01% |
109,740
-12,436
| -10% | -$132K |
|
|
MRNS
646
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.09M | 0.01% |
84,626
+24,706
| +41% | +$213K |
|
647
Park-Ohio Holdings
PKOH
$550M
| $1.07M | 0.01% |
66,893
+6,705
| +11% | +$107K |
|
648
Altisource Portfolio Solutions
ASPS
$58.4M
| $1.07M | 0.01% |
10,585
+3,064
| +41% | +$297K |
|
649
Neuronetics
STIM
$127M
| $1.07M | 0.01% |
+220,884
| New | +$838K |
|
650
Talos Energy
TALO
$2.38B
| $1.07M | 0.01% |
+165,620
| New | +$1.21M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.